Largest real-world study demonstrates significant survival advantage

ISM001-055 shows promise in improving lung function among patients

Preclinical data on NeuroRestore therapy to be showcased at CTAD in Madrid

Janssen-Cilag therapy becomes the first single tablet combination therapy for PAH in europe

New government scheme to offer routine opt-out blood tests

£3m programme to accelerate new antimicrobial treatment

International think tanks to shape future of cancer research funding

International trial marks leap forward in chemotherapy-induced neuropathy care